Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. (American journal of pathology, 2005)

(untitled) - Chen, Y; Shi-Wen, X; van Beek, J; Kennedy, L; McLeod, M; Renzoni, E; Bou-Gharios, G; Wilcox-Adelman, S; Goetinck, P; Eastwood, M; Black, C; Abraham, D; et al.